ALX Oncology(ALXO) - 2020 Q2 - Quarterly Report
ALXOALX Oncology(ALXO)2020-08-28 04:49

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39386 ALX ONCOLOGY HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 85-0642577 (State or other jurisd ...